You have 9 free searches left this month | for more free features.

SMA Type 2

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SMA II Trial in China (GC101)

Not yet recruiting
  • SMA II
  • GC101
  • Beijing, China
  • +4 more
Jun 15, 2023

Spinal Muscular Atrophy Trial in Reims (Monthly assessments of functional motor abilities by a trained therapist, Nusinersen)

Recruiting
  • Spinal Muscular Atrophy
  • Monthly assessments of functional motor abilities by a trained therapist
  • Nusinersen
  • Reims, France
    Damien JOLLY
Mar 16, 2022

Type 2 Spinal Muscular Atrophy Trial in Worldwide (OAV101, Sham control)

Recruiting
  • Type 2 Spinal Muscular Atrophy
  • OAV101
  • Sham control
  • Norfolk, Virginia
  • +10 more
Aug 17, 2022

Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type II Trial in Worldwide (Apitegromab)

Not yet recruiting
  • Spinal Muscular Atrophy
  • +9 more
  • Phoenix, Arizona
  • +26 more
Nov 15, 2022

Bulbar Function, Speech And Communication Development in SMA

Not yet recruiting
  • SMA1
    • (no location specified)
    Jul 12, 2023

    SMA Trial in Worldwide (Onasemnogene Abeparvovec-xioi)

    Completed
    • SMA
    • Onasemnogene Abeparvovec-xioi
    • Ghent, Belgium
    • +9 more
    Aug 12, 2022

    Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2 Trial in United States (Apitegromab,

    Recruiting
    • Spinal Muscular Atrophy
    • +9 more
    • Phoenix, Arizona
    • +9 more
    Jul 11, 2022

    Spinal Muscular Atrophy Trial in Beijing, Shenyang, Suzhou (GC101)

    Recruiting
    • Spinal Muscular Atrophy
    • GC101
    • Beijing, China
    • +3 more
    Apr 22, 2023

    Muscular Atrophy, Spinal, Type II, Muscular Atrophy, Spinal, Type III Trial in France (Strength force measurment, Time tests,

    Not yet recruiting
    • Muscular Atrophy, Spinal, Type II
    • Muscular Atrophy, Spinal, Type III
    • Strength force measurment
    • +6 more
    • Angers, France
    • +5 more
    Apr 20, 2023

    Spinal Muscular Atrophy Trial in Liège (Actimyo)

    Enrolling by invitation
    • Spinal Muscular Atrophy
    • Actimyo
    • Liège, Belgium
      Centre Hospitalier Régional de la Citadelle
    May 11, 2021

    Type2 Diabetes Trial in Las Vegas (Continuous Glucose Monitor (CGM), Activity Tracker, Coaching)

    Completed
    • Type2 Diabetes
    • Continuous Glucose Monitor (CGM)
    • +2 more
    • Las Vegas, Nevada
      Southwest Medical Associates
    Apr 27, 2021

    Spinal Muscular Atrophy Trial in France (Spinraza intrathecal injection)

    Recruiting
    • Spinal Muscular Atrophy
    • Spinraza intrathecal injection
    • Lyon, Auvergne Rhone Alpes, France
    • +6 more
    Jul 1, 2022

    Infantile Spinal Muscular Atrophy of Type 2 or 3 Trial in Garches (Physical exercise in a swimming pool during 6 months)

    Completed
    • Infantile Spinal Muscular Atrophy of Type 2 or 3
    • Physical exercise in a swimming pool during 6 months
    • Garches, Hauts-de-Seine, France
      Raymond Poincaré Hospital
    Apr 30, 2021

    Type 1 Diabetes Trial in Washington (SMA visits)

    Recruiting
    • Type 1 Diabetes
    • SMA visits
    • Washington, District of Columbia
      Children's National Hospital
    Aug 8, 2022

    Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

    Completed
    • Spinal Muscular Atrophy Type 3
    • Mitochondrial Myopathy
      • New York, New York
        Columbia University Medical Center
      Mar 7, 2022

      Muscle Atrophy Trial in Milano (Amifampridine Phosphate 10 MG Oral Tablet)

      Terminated
      • Muscle Atrophy
      • Amifampridine Phosphate 10 MG Oral Tablet
      • Milano, Lombardy, Italy
        Neurological Institute Carlo Besta
      Mar 14, 2022

      Spinal Muscular Atrophy Trial (OAV101)

      Recruiting
      • Spinal Muscular Atrophy
      • OAV101
      • Montreal, Quebec, Canada
      • +1 more
      Jan 31, 2023

      Spinal Muscular Atrophy Type I Trial in Japan, Korea, Republic of, Taiwan (Onasemnogene Abeparvovec-xioi)

      Completed
      • Spinal Muscular Atrophy Type I
      • Onasemnogene Abeparvovec-xioi
      • Tokyo, Japan
      • +3 more
      Nov 18, 2022

      Spinal Muscular Atrophy Trial in Worldwide (branaplam)

      Active, not recruiting
      • Spinal Muscular Atrophy
      • Gent, Belgium
      • +13 more
      May 16, 2022

      Pancreatic Adenocarcinoma Trial in Birmingham (No Periadventitial dissection of the SMA, Periadventitial dissection of the SMA)

      Recruiting
      • Pancreatic Adenocarcinoma
      • No Periadventitial dissection of the SMA
      • Periadventitial dissection of the SMA
      • Birmingham, County (Optional), United Kingdom
        University Hospitals Birmingham NHS Foundation Trust
      May 20, 2021

      Type 1 Diabetes Trial in Bern (SMA bolus option, Exactly estimated carbohydrate content bolus option)

      Not yet recruiting
      • Type 1 Diabetes
      • SMA bolus option
      • Exactly estimated carbohydrate content bolus option
      • Bern, Switzerland
        Department of Diabetes, Endocrinology, Nutritional Medicine and
      Aug 10, 2022

      Type 2 Diabetic Patients: Real-life Study on Effectiveness and

      Not yet recruiting
      • Diabete Type 2
        • (no location specified)
        Nov 2, 2023

        Glucagon-like Peptide-1 Receptor Agonists According to Type 2

        Recruiting
        • Diabetes Mellitus, Type 2
        • GLP-1 receptor agonist
        • Bari, Italy
          Azienda Ospedaliero-Universitaria Policlinico Bari
        Nov 4, 2023

        Diabetes Trial in Chiayi City (Shared Medical Appointments)

        Completed
        • Diabetes Mellitus
        • Shared Medical Appointments
        • Chiayi City, Chiayi, Taiwan
          Pin-Fan Chen
        Sep 4, 2023

        Muscular Atrophy, Spinal Trial in Milano (Amifampridine Phosphate, Placebo Oral Tablet)

        Completed
        • Muscular Atrophy, Spinal
        • Amifampridine Phosphate
        • Placebo Oral Tablet
        • Milano, Lombardy, Italy
          Neurological Institute Carlo Besta
        May 28, 2021